title: [Transarterial hepatic embolization of metastatic liver cancers with reference to 17 cases of survival for more than 2 years].
abstract: The evaluation of TAE was studied for 73 patients with metastatic liver cancers but without metastasis in other organs, who were treated with initial TAE more than 2 years ago. Seventeen patients survived for more than 2 years. The primary lesions consisted of colon cancer in 9 patients, the Langerhans islet cell tumor of the pancreas in 4, gastric cancers in 2, breast cancer in 1 and leiomyosarcoma of the colon in 1. The overall 2-year survival rate calculated by the direct method was 23.3% and mean survival period was 15.8 months. The prognosis was good in H1 and V3. Lp-TAE produced better effects but no statistically significant difference was found between the 2-year survivals by Lp-TAE and by GS-TAE.
authors.affiliation: Department of Radiology, Nara Medical University.
authors.forename: O
authors.initials: O
authors.lastname: Satoh
authors.forename: H
authors.initials: H
authors.lastname: Sakaguchi
authors.forename: T
authors.initials: T
authors.lastname: Yoshioka
authors.forename: N
authors.initials: N
authors.lastname: Nagano
authors.forename: H
authors.initials: H
authors.lastname: Nakagawa
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshimura
authors.forename: H
authors.initials: H
authors.lastname: Ohishi
authors.forename: H
authors.initials: H
authors.lastname: Uchida
authors.forename: J
authors.initials: J
authors.lastname: Tsushima
authors.forename: S
authors.initials: S
authors.lastname: Ohue
mesh_terms: D000328:Adult; D000368:Aged; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015996:Survival Rate